GERON CORPORATION

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 6838
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 4184
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 39128
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 37218
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 2475
 
  
 
C07K PEPTIDES 8128
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 590
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 3203
 
  
 
A23J PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS 218
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 247

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2016/0312,227 METHODS OF POLYNUCLEOTIDE PREPARATION USING MULTIVALENT CATION SALT COMPOSITIONSApr 21, 16Oct 27, 16[C12N]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9822360 RNA amidates and thioamidates for RNAiAug 06, 15Nov 21, 17[C07H, A61K, C12N, A61P]
9796747 Oligonucleotide compositions and methods of making the sameApr 29, 15Oct 24, 17[C07H, C12P, C12N]
9771581 C-myc antisense oligonucleotides and methods for using the same to treat cell-proliferative disordersDec 02, 15Sep 26, 17[C07H, C12N]
9765109 2′-arabino-fluorooligonucleotide N3′→P5′ phosphoramidates: their synthesis and useSep 11, 14Sep 19, 17[C07H, C12Q, C12N]
9732114 Compounds having anti-adhesive effects on cancer cellsJul 21, 14Aug 15, 17[C07H, A61K]
9708360 Phosphorodiamidate backbone linkage for oligonucleotidesSep 26, 14Jul 18, 17[A61K, C07H]
9657296 Modified oligonucleotides for telomerase inhibitionMay 18, 15May 23, 17[A61K, C07H, C12N, C07C]
9624542 Telomere length measurement in formalin-fixed, paraffin embedded (FFPE) samples by quantitative PCRMar 26, 12Apr 18, 17[C12Q, C12P, G01N]
9617583 Method for identification of sensitivity of a patient to telomerase inhibition therapyOct 02, 14Apr 11, 17[A61K, C07H, C12Q]
9593137 Guanine analogs as telomerase substrates and telomere length affectorsDec 21, 12Mar 14, 17[C07F, C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0051,287 USE OF TELOMERASE INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS AND MYELOPROLIFERATIVE NEOPLASMSAbandonedMay 25, 16Feb 23, 17[C12N]
2015/0359,883 Treatment of Carcinomas with a Combination of EGF-Pathway and Telomerase InhibitorsAbandonedAug 31, 15Dec 17, 15[A61K]
2015/0344,963 DIAGNOSTIC MARKERS FOR TREATING CELL PROLIFERATIVE DISORDERS WITH TELOMERASE INHIBITORSAbandonedNov 27, 13Dec 03, 15[C12Q, C12N]
2015/0342,982 Use of Telomerase Inhibitors for the Treatment of Myeloproliferative Disorders and Myeloproliferative NeoplasmsAbandonedNov 15, 13Dec 03, 15[A61K, C12N]
2015/0250,863 Method for Eliciting an Immune Response to Human Telomerase Reverse TranscriptaseAbandonedFeb 25, 14Sep 10, 15[A61K, C12N]
2014/0349,292 OLIGONUCLEOTIDE N3'-->P5' THIOPHOSPHORAMIDATES: THEIR SYNTHESIS AND USEAbandonedJul 09, 14Nov 27, 14[C07H, C12Q, C12N]
2012/0329,858 MODIFIED OLIGONUCLEOTIDES FOR TELOMERASE INHIBITIONAbandonedAug 21, 12Dec 27, 12[A61K, C07H, C12N, A61P]
2012/0129,918 MODIFIED OLIGONUCLEOTIDES FOR TELOMERASE INHIBITIONAbandonedSep 20, 10May 24, 12[A61K, C07H, C12N, A61P]
2012/0070,842 Assay for Telomerase Activity Using Microfluidic DeviceAbandonedMay 28, 10Mar 22, 12[C12Q]
2009/0286,853 MODIFIED OLIGONUCLEOTIDES FOR TELOMERASE INHIBITIONAbandonedNov 21, 08Nov 19, 09[A61K, C07H, C12N, A61P]
7585622 Increasing the proliferative capacity of cells using telomerase reverse transcriptaseExpiredNov 02, 99Sep 08, 09[C12Q, C12P, C12N]
7585966 Inhibitory polynucleotides directed against the RNA component of telomeraseExpiredNov 08, 99Sep 08, 09[C07H]
2009/0191,634 (METH)ACRYLATE SURFACES FOR CELL CULTURE, METHODS OF MAKING AND USING THE SURFACESAbandonedJan 30, 09Jul 30, 09[C08J, C08F, C12N]
7560437 Nucleic acid compositions for eliciting an immune response against telomerase reverse transcriptaseExpiredJan 11, 02Jul 14, 09[A61K, C07H]
2009/0142,770 Hair Follicle Pharmacodynamic Assay for Telomerase ActivityAbandonedDec 03, 08Jun 04, 09[C12Q]
2009/0111,157 Protein and peptide fragments from mouse telomerase reverse transcriptaseAbandonedJun 28, 07Apr 30, 09[C12N]
7517971 Muteins of human telomerase reverse transcriptase lacking telomerase catalytic activityExpiredNov 22, 00Apr 14, 09[C07H, C12N]
2008/0220,438 Telomerase Promoter Sequences for Screening Telomerase ModulatorsAbandonedApr 25, 08Sep 11, 08[C12Q]
2007/0122,501 Formulations containing astragalus extracts and uses thereofAbandonedJun 25, 04May 31, 07[A61K]
2007/0037,770 Oligonucleotide N3'-P5' thiophosphoramidates: their synthesis and useAbandonedOct 25, 06Feb 15, 07[A61K, C07H, C12Q]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.